Skip to main content

VXRT

Stock

VXRT

Stock
Health Care
Biotechnology

Performance overview

VXRT Price
Price Chart

Forward-looking statistics

Beta
0.65
Risk
93.39%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

since its founding in 2004, vaxart has pursued a vision of advancing vaccines—to make them as tablets rather than injections. the company’s proprietary oral vaccine delivery platform is suitable to deliver any recombinant vaccine, positioning vaxart to introduce oral forms of multiple vaccines in the rapidly growing global vaccines market.

Company info

SectorHealth Care
IndustryBiotechnology
Employees124
Market cap$136.4M

Fundamentals

Enterprise value$81.8M
Revenue$47.4M
Revenue per employee
Profit margin-122.63%
Debt to equity45.07

Security info

ExchangeNASDAQ
Type of shareCommon Stock
Earnings per share (EPS)-$0.26
Dividend per share
Revenue per share$0.22
Avg trading volume (30 day)$3M
Avg trading volume (10 day)$1M
Put-call ratio

Macro factor sensitivity

Growth+4.1
Credit+2.7
Liquidity-1.7
Inflation-1.4
Commodities+2.6
Interest Rates-0.5

Valuation

Dividend yield0.00%
PEG Ratio-1.04
Price to sales2.06
P/E Ratio-1.04
Enterprise Value to Revenue1.73
Price to book2.13

Upcoming events

Next earnings dayMay 14, 2025
Next dividend day
Ex. dividend dayNovember 9, 2012

News

VAXART, INC. (VXRT) Reports Q4 Loss, Lags Revenue Estimates

VAXART, INC. (VXRT) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.10.

Zacks Investment Research (March 20, 2025)
Oral Vaccine Focused Penny Stock Vaxart Is 'Uniquely Positioned', Analyst Sees Almost 83% Upside

Oppenheimer initiated coverage on Vaxart Inc. VXRT, an American biotechnology company focused on the discovery, development, and commercialization of oral recombinant vaccines.

Benzinga (August 15, 2024)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free